Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added. The previous v3.4.1 notice governing government funding and potential delays has been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedA government funding lapse notice has been added, stating that information may not be up to date and submissions may be delayed. The page revision has been updated to v3.4.1, replacing v3.4.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page shows minor UI text changes including a visible 'Show glossary' option, capitalization tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows an updated revision label: v3.3.4 was added and the previous v3.3.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Locations section lists study sites across the US, Australia, and Puerto Rico (rev. 3.3.3). The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. This update shows the site versioning and does not alter the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.